RARE-DISEASES

RARE-DISEASES

Cancer patients need more time. Accelerated approval helps give them that.

Introduction Cancer is one of the most devastating diseases humanity has faced, with millions of patients worldwide struggling to manage its relentless progression. For those diagnosed with cancer, every minute counts. The FDA's Accelerated Approval Program (AAP) has been a beacon of hope for these patients, providing earlier access to critical treatments that can extend their lives..

RARE-DISEASES

How Is The Market Feeling About Biomarin Pharmaceutical?

BioMarin Pharmaceutical, a leading biotech company focused on raredisease therapies, has been making waves in the market..

RARE-DISEASES

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.

In a significant development in the pharmaceutical industry, Danish company H Lundbeck A/S has agreed to acquire U.S.based Longboard Pharmaceuticals in a $2.6 billion deal. This acquisition has sent Longboard Pharmaceuticals' stock soaring by over 51% in premarket trading, marking one of the most substantial gains in recent market history..